Article: Nabi Biopharmaceuticals Acquires Exclusive North American Commercialization Rights to Phase III Antibody Product for Prevention and Treatment of Rejection Following Organ Transplantation.

Article: Xcyte Therapies, Inc. and Fresenius Biotech GmbH ...
Business Wire;  January 15, 2004 ;     700+ words ... ... announced that it will collaborate with Fresenius Biotech GmbH, a division of Fresenius AG ... Gottwald, MD, PhD, President of Fresenius Biotech. "Therefore, we have partnered ... partnership may meet this need." Fresenius Biotech GmbH is a company within the Fresenius ...

Article: Enzon returns rights to transplant product to Fresenius ...
Transplant News;  January 13, 2006 ;     678 words ... ... announced it is returning its rights to ATG-Fresenius S to Fresenius Biotech GmbH, a subsidiary of the health care company Fresenius ... recipients. Enzon says its decision to return full rights to Fresenius Biotech was based on its ongoing efforts to redirect its research ...

Article: Enzon Returns Rights to Transplantation Product to ...
Business Wire;  January 6, 2006 ;     700+ words ... ... that it is returning its rights to ATG-Fresenius S to Fresenius Biotech GmbH, a subsidiary of the health care company Fresenius ... Fresenius S. Enzon's decision to return full rights to Fresenius Biotech was based on its ongoing efforts to redirect its research ...

Article: Publication No. WO/2009/106096 Published on Sept. 3, Assigned to ...
US Fed News Service, Including US State News;  September 10, 2009 ;     435 words ... ... Germany, have developed a treatment of resistant tumors with trifunctional antibodies. The patent has been assigned to FRESENIUS BIOTECH GmbH, Grafelfing, Germany. According to an abstract posted by the World Intellectual Property Organization, the invention ...

Article: Nabi, Fresenius sign agreement to advance ATG-Fresenius S in the ...
Transplant News;  April 17, 2006 ;     700+ words ...Nabi Biopharmaceuticals, Boca Raton, FL, announced it has signed an agreement with Fresenius Biotech, Bad Homburg, Germany, to advance ... Under terms of the agreement, Fresenius Biotech has granted Nabi exclusive sales ...

Article: Shareholders alert for Nabi Biopharmaceuticals.
M2 Presswire;  May 2, 2007 ;     700+ words ... ... In addition, Nabi Biopharmaceuticals offers contract ... stage companies. Nabi Biopharmaceuticals serves wholesalers ... ProMetic, and Fresenius Biotech. The company ... information on Nabi Biopharmaceuticals are invited to ...

Article: Nabi Biopharmaceuticals Acquires Exclusive Rights ...
PR Newswire;  August 29, 2006 ;     700+ words ... ... PRNewswire-FirstCall/ -- Nabi Biopharmaceuticals today announced that it has obtained ... the manufacture of certain of Nabi Biopharmaceuticals' pipeline hyperimmune products ... expected to provide higher yields of Nabi Biopharmaceuticals' Civacir(R) [Hepatitis C ...